Delivery Order 36F79720D0237-15B50526F00000027
- This is a Firm Fixed Price contract awarded to Bayer Healthcare Pharmaceuticals Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20. The contract is a Blanket Purchase Agreement (BPA) Call under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with a potential value of $225,918.94. Bayer Healthcare Pharmaceuticals Inc. will provide the drug Riociguat (Adempas) 1mg tablets to the VA. This contract does not...
- The Department of Veterans Affairs (VA) awarded a delivery order contract to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of Bayer AG, for the drug Adempas. The $111,792.56 firm fixed price contract is for the delivery of this pharmaceutical product to support the VA's healthcare programs. The contract is not set aside for any small business category. Bayer Healthcare Pharmaceuticals Inc. has previously provided drugs such as Xarelto, Xofigo, and other medical supplies to the VA and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 awarded a firm fixed price blanket purchase agreement call contract valued at approximately $38,000 to Bayer Healthcare Pharmaceuticals Inc. to support pharmacy ordering of the pulmonary arterial hypertension drug Adempas for fiscal year 2019. The contract was awarded on June 24, 2019 under the Pharmaceuticals and Drugs schedule of the General Services Administration Federal Supply Schedule...
- This is a firm fixed-price BPA call order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bayer Healthcare Pharmaceuticals Inc. to provide pharmaceuticals for the 3rd quarter of fiscal year 2017. The order, which has a potential value of $132,045.64, is placed under Bayer's existing Indefinite Delivery Vehicle (IDV) contract on the Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB). Bayer, a major supplier of pharmaceuticals and medical products...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG. The $687,904.53 Firm Fixed Price Delivery Order is for the supply of radio pharmaceuticals and is part of a larger $840 million Multiple Award Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs. The contract has no set-aside designation, reflecting Bayer's status as a large, foreign-owned...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Bayer Healthcare Pharmaceuticals Inc., a major pharmaceutical supplier, for $193,983.32. The contract is for the delivery of various medical products, including pharmaceuticals, radioactive isotopes, contrast media injections, implants, and other medical supplies. The order is a firm fixed price contract with a completion date of April 8, 2019. Bayer Healthcare Pharmaceuticals Inc. has previously...
- This federal contract award to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG, is for the delivery of Xofigo (radium Ra 223 dichloride), a radiopharmaceutical used to treat prostate cancer. The $101,005.97 firm fixed-price delivery order was issued by the U.S. Department of Veterans Affairs (VA), under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. This multiple-award schedule contract has a potential value of $840...
- This is a delivery order issued against the Department of Veterans Affairs (VA) Federal Supply Schedule (FSS) contract V797P-2202D for Pharmaceuticals and Drugs. The $91,108.93 contract was awarded to Bayer Healthcare Pharmaceuticals Inc., a large, foreign-owned, for-profit pharmaceutical company, to provide a one-month supply of the medication Kogenate FS. The award was made on May 24, 2016 with an ultimate completion date of June 21, 2016. This delivery order was placed by the Federal...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization, for the provision of pharmaceutical medications. The award, valued at $130,520.26, was made under a VA Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), and has a delivery order contract type with a firm fixed price. The contract supports the VA's healthcare programs for veterans and active-duty...
- Bayer Healthcare Pharmaceuticals Inc., a subsidiary of Bayer AG focused on pharmaceuticals and medical products, has been awarded a $56,933.69 delivery order for radium-223 (Xofigo) isotopes by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17. The delivery order was issued on October 1, 2022 against Bayer's multiple award schedule contract for pharmaceuticals and drugs, referred to as FSS-61-IB, with performance required by September 30,...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79720D0237Federal Supply Schedule
- 36F79720D0237-15B50526F00000027Delivery Order
Bayer Healthcare Pharmaceuticals Inc., a subsidiary of global pharmaceutical firm Bayer AG, was awarded a delivery order valued at $12.2K for 90-count bottles of ADEMPAS (riociguat) 1 mg tablets with a completion date of December 31, 2025. The award was issued under a firm fixed-price contract structure with no small business set-aside designation. The pharmaceutical product will be delivered to the Federal Medical Center Carswell, a civilian medical facility operated by the U.S. Department of Justice's Bureau of Prisons, with the place of performance located in Whippany, Hanover, New Jersey. This delivery order is issued under Bayer Healthcare Pharmaceuticals Inc.'s $840 million multiple-award Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the Department of Veterans Affairs, which enables various federal agencies to rapidly procure essential medications. ADEMPAS is a specialized pharmaceutical used to treat pulmonary arterial hypertension, and Bayer maintains a significant $6.8 million Blanket Purchase Agreement with the VA National Acquisition Center specifically covering ADEMPAS and Xofigo products through October 2026. As a large, foreign-owned enterprise, Bayer Healthcare Pharmaceuticals Inc. has established itself as a key supplier of critical pharmaceutical products across federal healthcare networks, including the VA, Defense Logistics Agency, and other civilian federal medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 12/2/25 |